CDK16 and colorectal carcinoma: 2.8. Pharmacological Targeting BMPR1B-SMAD1/5/8 Signaling with Small Molecules Inhibited the Promotion of PCTK1 Knockout on CRC Cell Malignant Phenotype and Chemoresisitance